Virtual Medicinal Product (VMP) - Mometasone 400micrograms/dose dry powder inhaler

Name Details

Name Start Date End Date
Name Current Name Mometasone 400micrograms/dose dry powder inhaler Start Date 16-08-2006 End Date
Previous Name Previous Name Mometasone 400micrograms/actuation dry powder inhaler Start Date 10-03-2003 End Date 15-08-2006

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
dose
Unit Dose UOM
dose

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Inhalation
Form
Inhalation powder
Ontology Form/Route
powderinhalation.inhalation
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
R03BA07
BNF Start Date End Date
Current BNF 03020000 Start Date 04-04-2022 End Date
Previous BNF 03020000 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
38895611000001107 19-08-2020
408013007 19-08-2005 18-08-2020
4053911000001106 10-03-2003 18-08-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Mometasone furoate Based on Ingredient Substance 400 microgram 1 dose

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 dose 2178 Part VIIIA Category C
60 dose 3605 Part VIIIA Category C